Stem Cell TV | Video / Media News

Page 1,769«..10 20..1,7681,7691,770 1,771..1,780 1,790..»

Stem Cell Therapy & Stem Cell Treatment – Cell Therapy …

Posted: August 20, 2015 at 9:41 am

Our Cell Therapy Center offers advanced patented methods of stem cell treatment for different diseases and conditions. The fetal stem cells we use are pluripotent non-specialized cells able to differentiate (turn) into other cell types. Fetal stem cells have the highest potential for differentiation and proliferation and are not rejected by the recipients body more...

Stem cell therapy has proven to be effective for tissue restoration, and integrated care for the incurable and obstinate diseases. We treat patients with various diseases, such as diabetes mellitus, multiple sclerosis, Parkinsons disease, Duchenne muscular dystrophy, joint and autoimmune diseases, etc. We also offer innovative anti-aging programs. Stem cell treatment allows for achieving effects that are far beyond the capacity of any other modern method more...

For over 21 years, we have performed more than 8,500 transplantations of fetal stem cells to people from many countries, such as the USA, China, Italy, Germany, Denmark, Great Britain, Saudi Arabia, UAE, Egypt, etc. Our stem cell treatments helped to prolong life and improve life quality to thousands of patients including those suffering from the incurable diseases who lost any hope for recovery.

With Cell Therapy Center EmCell located in Kiev, Ukraine, we have numerous partners in various countries devoted to provide medical advice on EmCell stem cell treatment locally.

We are always open for medical, businessandscientificcooperation.

Posted in Stem Cell Treatments | Comments Off

Humanity Plus

Posted: August 19, 2015 at 11:44 pm

Humanity+ is an international nonprofit membership organization that advocates the ethical use of technology to expand human capacities. In other words, we want people to be better than well.

Our Humanity+ conferences explore innovations of science and technology and their relationship to humanity. Recent conferences have been held at San Francisco State University, Polytechnic University in Hong Kong, Parsons The New School for Design in New York City, California Technology Institute, and Harvard University.

H+ Magazine covers technological, scientific, and cultural trends that are changing humans in fundamental ways. H+ Magazine aims to reflect the newest edge culture by featuring creative expressions of humanity on a razors edge where daily life and science fiction seem to be merging.

H+ Connect is a dynamic social network for Humanity+ members and other transhumanists throughout the world. We hope H+ Connect will offer a unique environment for people to share what they are working on, meetup with others.

Join a Chapter or start one! There are many possible activities for local groups, from purely social gatherings to study groups and speaker series. All local chapters are autonomous, except insofar as we recognize and cooperate with you.

The Humanity+ Student Network is an international coalition of student organizations dedicated to discussing transhumanist ideas. The H+SN and its member groups seek to provide opportunities for university-level work and research in exploring the promises and perils of technology and the future of humanity.

More here:
Humanity Plus

Posted in Transhumanist | Comments Off

index | WVU Statler College

Posted: August 18, 2015 at 5:49 pm

See more stories here Chemical engineering combines chemistry with mathematics and economics to solve problems and to find safe, efficient, and environmentally benign ways of making useful products.

The Department provides educational programs at the bachelor's, master's, and doctoral levels. WVU offers electives for specialization in such fields as electronic materials and polymers, and an undergraduate certificate program in biomedical engineering. Open-ended design problems are introduced from the beginning, and grow in complexity as students become more proficient. As part of a capstone design course, seniors organize and operate as a team to solve a real industry problem. Faculty in the Department are involved in an active program of innovative research areas including biochemical and biomedical engineering, carbon products, catalysis and reaction engineering, fluidization, fuels, natural-gas hydrates, particle science and powder technology, polymers and composites, and semiconductor processing. Scholarships are available.

The chemical engineering curriculum is designed to give graduates a broad background in chemical engineering processes and to prepare them to become professional engineers. Students are prepared for positions in operation, development, design, construction, and management of industrial plants. These industries subject raw materials to chemical and physical changes and produce economically desirable products. Graduates are also qualified for positions with research institutions and government agencies. Learn more about our student outcomes.

The Chemical Engineering Department at West Virginia University, Statler College of Engineering and Mineral Resources' vision will be realized by:

Read this article:
index | WVU Statler College

Posted in West Virginia Stem Cells | Comments Off

STEM All-Female High School Camp – West Virginia University

Posted: August 18, 2015 at 5:49 pm

The Statler College will be hosting six weeks of Engineering Challenge Camps in June and July 2016.

If you would like to sign up to receive information about our 2016 Engineering Challenge Camps when it becomes available, please click here.

High School camps run as overnight camps, and the campers will have the opportunity to stay in a WVU residence hall. All meals and evening programming will be provided.

Middle School camps run as week-long, full day camps, 9 a.m.to 5 p.m. with lunch included. Projects will be different than previous years. Each week of camp will have the same curriculum

Elementary camps will run as week-long,half-day camps with 1st, 2nd, and 3rd Grade from 9:00 a.m. to 12:30p.m. and 4th and 5th graders from 1 to 5 p.m. The projects will be different than the projects of the previous year. Each week will have the same curriculum.

If you have any questions about camp, please email Cate Schlobohm or call her at 304-293-0399.

Camp FAQ's

Engineering in Action High School Camp 2015

Growing Roots in STEM All-Female High School Camp 2015

Maker--High School Camp 2015

Elementary Engineering Challenge Camp (Week 1) 2015

Elementary Engineering Challenge Camp (Week 2) 2015

Middle School Engineering Challenge Camp (Week 1) 2015

Middle School Engineering Challenge Camp (Week 2) 2015

Sustainability Focused High School Camp 2014

Engineering in Action High School Camp 2014

Growing Roots in STEM All-female Camp 2014

Middle School Exploration Camp 2014

Elementary Camp 2014

Are you interested in what activities your child would be involved with at an engineering camp? If so, check out the agendas from the Statler College's 2015 camps.

2015 Growing Roots in STEM Engineering Challenge Camp Agenda

2015 Maker Focused Co-Ed High School Camp Agenda

2015 Engineering in Action Co-Ed High School Camp Agenda

2015 Engineering in Entertainment Camp Agenda

2015 Middle School Exploration Camp Agenda

2015 Elementary Camp- 1st, 2nd, and 3rd Grade Agenda

2015 Elementary Camp- 4th and 5th Grade Agenda

See the original post here:
STEM All-Female High School Camp - West Virginia University

Posted in West Virginia Stem Cells | Comments Off

Seattle Genetics: Advancing Antibody-Drug Conjugates for …

Posted: August 18, 2015 at 5:45 pm

Full Prescribing Information

Indications and Important Safety Information, Including Boxed Warning

ADCETRIS Indications ADCETRIS (brentuximab vedotin) Injection for intravenous infusion has been granted accelerated approval by the U.S. Food & Drug Administration for two indications:

These indications are approved under accelerated approval based on overall response rate. An improvement in patient-reported outcomes or survival has not been established. Continued approval for these indications may be contingent upon verification and description of clinical benefit in confirmatory trials.

BOXED WARNING Progressive multifocal leukoencephalopathy (PML): JC virus infection resulting in PML and death can occur in patients receiving ADCETRIS.

Contraindication ADCETRIS is contraindicated with concomitant bleomycin due to pulmonary toxicity (e.g., interstitial infiltration and/or inflammation).

Warnings and Precautions

Adverse Reactions ADCETRIS was studied as monotherapy in 160 patients in two phase 2 trials. Across both trials, the most common adverse reactions (20%), regardless of causality, were neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough and vomiting.

Drug Interactions Concomitant use of strong CYP3A4 inhibitors or inducers, or P-gp inhibitors, has the potential to affect the exposure to monomethyl auristatin (MMAE).

Use in Specific Populations MMAE exposure and adverse reactions are increased in patients with moderate or severe hepatic impairment or severe renal impairment. Avoid use.

Full Prescribing Information, including Boxed WARNING - U.S.

The rest is here:
Seattle Genetics: Advancing Antibody-Drug Conjugates for ...

Posted in Genetics | Comments Off

Stem Cell Therapy | Cellular Prolotherapy | Caring Medical

Posted: August 18, 2015 at 12:42 pm

Home Stem Cell Therapy | Cellular Prolotherapy

Ross Hauser, MD

Ross Hauser, MD: the use of Stem Cell Therapy in the treatment of joint and spine degeneration.

Stem cell therapy is exploding in the medical field, and for good reason. Stem cells have the potential to regenerate into any type of body tissue. The amazing thing about stem cells is that when you inject them into the body, they know what kinds of cells your body needs for example, meniscus cells or cartilage cells. It is a very exciting time for medicine, especially in the field of regenerative medicine. In our office we often refer to this as Cellular Prolotherapy.

In Stem Cell Therapy we use a persons own healing cells from bone marrow, fat, and blood (alone or in various combinations) and inject them straight to the area which has a cellular deficiency.

The goal is the same: to stimulate the repair of injured tissues. Stem cells aid in fibroblastic proliferation where cell growth, proteosynthesis, reparation, the remodeling of tissues, and chondrocyte proliferation occurs. Our bone marrow contains stem cells,also termed mesenchymal stem cells and progenitor cells, among other names. These immature cells have the ability to become tissues like cartilage, bone, and ligaments.

Consequently, researchers and clinicians are focusing on alternative methods for cartilage preservation and repair. Recently,cell-basedtherapyhas become a key focus of tissue engineering research to achieve functional replacement of articular cartilage.1

Not all injuries require stem cells to heal. For many patients the success rate with traditionalProlotherapyin this office is in the 90%+ range for all patients. However, for those cases of advanced arthritis, meniscus tears, labral tears, bone-on-bone, or aggressive injuries, our Prolotherapy practitioners may choose to use stem cell injections to enhance the healing, in combination with dextrose Prolotherapy to strengthen and stabilize the surrounding support structures formeniscus repair.

In our research published inThe Open Stem Cell Journal,Rationale for Using Direct Bone Marrow Aspirate as a Proliferant for Regenerative Injection Therapy(Prolotherapy). We not only showed the benefit of bone marrow derived stem cells as a Prolotherapy proliferant solution, but also that this exciting field of medicine needs doctors and scientisists working together to expand research and technique guidelines.

Typically the tissue that we are trying to stimulate to repair with Stem Cell Therapy or Cellular Prolotherapy is articular cartilage, but we can also proliferate soft tissues structures such as ligament and tendons. This is new technology so we are studying it as we use it to treat patients.

We chose to review this study to support our research and to inform people about the human studies usingbone marrow stem cellsfor articular cartilage lesions. Articular cartilage is a type of cartilage that covers joint surfaces and is most susceptible to injury compared to other types of cartilage.

Researchers at Cairo University School of Medicine and the University of Pittsburgh School of Medicine reported on the use of bone marrow mesenchymal stem cells and aplatelet-richfibrin scaffold to heal full-thickness cartilage defects in five patients. The researchers studied the treatment results from the bone marrow mesenchymal stem cells which were used in a platelet rich fibrin glue, placed on the tear and covered with a flap of the patients cartilage.

Platelets were used as a scaffold because platelets contain various growth factors that stimulate cartilage regeneration. The researchers expected that the biological effect of multiplegrowth factorson tissue regeneration is greater that of a single growth factor.

Results

The patients showed significant functional improvement. Two of the patients underwent arthroscopy after the transplantation and showed near normal articular cartilage. Three postoperative MRIs revealed complete healing and congruent cartilage tissue, whereas two patient MRIs showed incomplete congruity in the cartilage tissue.

Conclusion

Osteoarthritis is a cartilage degenerative processNo treatment is still available to improve or reverse the process. Stem cell therapy opened new horizons for treatment of many incurable diseasesIn this research four patients with knee osteoarthritis were selected for the study. They were aged 55, 57, 65 and 54 years, and had moderate to severe knee Osteoarthritis. After their signed written consent, 30 mL of bone marrow were taken and cultured for MSC growth. After having enough MSCs in culture (4-5 weeks) and taking in consideration all safety measures, cells were injected in one knee of each patient.

The walking time for the pain to appear improved for three patients and remained unchanged for one. On physical examination, the improvement was mainly for crepitus. It was minor for the improvement of the range of motion.

Results were encouraging, but not excellent. Improvement of the technique may improve the results.4

Platelet Rich Plasma contains a myriad of substances that stimulate healing:

Numerous studies have shown that PRP enhances the effects of Stem Cell Therapy5,6As the study above notes Results were encouraging, but not excellent. Improvement of the technique may improve the results. Platelet Rich Plasma therapy improves the technique and improves the results.

Our ultimate goal withallforms of Prolotherapy is to get the patients back to doing the things that they want to do without pain. It is our hope that the Stem Cell Therapy (Cellular Prolotherapy) treatments will form functionally, structurally, and mechanically equal to, if not better than, living tissue which has been designed to replace (or work alongside of) damaged tissue. It is hard to prove the above statement because we cannot sacrifice human beingsafterProlotherapy to see if the tissue looks and acts normally. Wecan, however, report that the majority of our patients who receive Stem Cell Therapy along with traditional Hackett-Hemwall Prolotherapy get back to activities and have dramatically decreased pain levels using this comprehensive approach.

Links to our other articles for your specific conditions

A page with more information on stem cell injection treatments combined with Prolotherapy and PRP Treatments for back pain.

In this article wediscusses research that showsthatstem cell injection therapywill aid in the repair ofarticular cartilageandmeniscus tears. The treatment relieves symptoms of stiffness,pain, disability, and inability to walk as commonly reported by our patients diagnosed with knee osteoarthritis.

Many patients have many questions about stem cell tretament for knee osteoarthritis, lets hear yours.

References for this article

1.Mazor M, Lespessailles E, Coursier R, et al.Mesenchymal stem-cell potential in cartilage repair: an update. J Cell Mol Med. 2014 Oct 29. doi: 10.1111/jcmm.12378. 2. Diekman BO, Guilak F.Stem cell-based therapies for osteoarthritis: challenges and opportunities. Curr Opin Rheumatol. 2013 Jan;25(1):119-26. doi: 10.1097/BOR.0b013e32835aa28d. 3. Hauser RA, Orlofsky A.Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: a case series.Clin Med Insights Arthritis Musculoskelet Disord. 2013 Sep 4;6:65-72. doi: 10.4137/CMAMD.S10951. eCollection 2013. 4. Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteo
arthritis. Preliminary report of four patients. Int J Rheum Dis. 2011 May;14(2):211-5. doi: 10.1111/j.1756-185X.2011.01599.x. Epub 2011 5. Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V, Jacobs CR. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. 2009 Sep;15(3):431-5. 6. Kasten P, Vogel J, Beyen I, Weiss S, Niemeyer P, Leo A, Lginbuhl R. Effect of platelet-rich plasma on the in vitro proliferation and osteogenic differentiation of human mesenchymal stem cells on distinct calcium phosphate scaffolds: the specific surface area makes a difference. J Biomater Appl. 2008 Sep;23(2):169-88. Epub 2008 Jul 16.

View post:
Stem Cell Therapy | Cellular Prolotherapy | Caring Medical

Posted in Cell Therapy | Comments Off

Stem Cell Safety

Posted: August 17, 2015 at 1:40 am

Author: Ian Murnaghan BSc (hons), MSc - Updated: 13 November 2013 | Comment

It is an unfortunate reality that the therapies often holding the most potential also carry numerous queries regarding their safety. Stem cells are one such topic of concern - their potential to treat disease is exciting but their safety concerns have kept them from being approved for many treatments, despite their initial indications of promising success.

Clearly, stem cell safety must be scrutinised and assessed throughout the entire treatment or research process. Guidelines and strategies must also be developed to ensure that every aspect of stem cell use - from identification and isolation of stem cells to stem cell transplant - is stringently coordinated. Stem cell lines must be adequately screened for disease and the sources must be examined in depth. If doctors and scientists can establish safe protocols for stem cell use, everyone can benefit from the full potential of the remarkable and possibly life-saving stem cell therapies.

Therapeutic Cloning – Explore Stem Cells

Posted: August 17, 2015 at 1:40 am

Author: Ian Murnaghan BSc (hons), MSc - Updated: 14 August 2015 | Comment

When people think of the word 'cloning' they are often hit with frightening images of duplicate human beings being created in somewhat of a mad scientist style experiment. In fact, many members of the public were outraged when "Dolly" the sheep resulted from a cloning experiment in Scotland.

Therapeutic cloning, however, is entirely different and does not involve the creation of a perfectly copied human being. It is reproductive cloning that results in a copy of a specific human being. In therapeutic cloning, no sperm fertilisation is involved nor is there implantation into the uterus to create a child.

Therapeutic cloning is also important to enhancing our understanding of stem cells and how they and other cells develop. This understanding can hopefully lead to new treatments or cures for some of the common diseases affecting people today. In addition, the procedure would allow for scientists to create stem cell therapies that are patient specific and perfectly matched for the patient's medical condition.

Therapeutic cloning does result in the destruction of an embryo after stem cells are extracted and this destruction has stirred controversy over the morality of the procedure. Some argue that the pros outweigh the cons with regards to treating disease whilst others have likened the destruction to an abortion. Still others state that this doesn't change the fact the embryo could potentially be a human being and so destruction of the embryo is no different than destruction of a human life.

Because reproductive cloning does utilise SCNT as the primary step, there is also still fear that given our knowledge base to perform reproductive cloning, a scientist may attempt to move beyond therapeutic cloning to creation of a human being.

To this date, no human being has been successfully cloned but the possibility of this occurring is a frightening one not only for the general public and policy makers, but also for most of the ethical scientific field. The majority of scientists are adamantly opposed to reproductive cloning and instead, support therapeutic cloning for Treating Disease. With policies and careful monitoring in place to ensure that therapeutic cloning is used responsibly, we can all benefit from the potential of this procedure to eventually treat, or perhaps one day cure, many diseases.

Stem cell – ADULT STEM CELL THERAPY IS AVAILABLE NOW!

Posted: August 17, 2015 at 1:40 am

Australia - New Zealand - Asia & Pacific Rim - China - Italy

The Foundation is a privately funded philanthropic (non profit) organization advising un-well people about how to gain access to Adult Stem Cell Therapy (ASCT). The Foundation is also promoting a plan to its members on how to prevent or limit the progression of degenerative diseases and other conditions. Degenerative disease is an escalating world problem that, if not controlled, could bankrupt our health systems.

A major objective of the Foundation is to highlight that people suffering from degenerative conditions now have the option of considering Adult Stem Cell Therapy. This therapy may improve quality of life for sufferers of Arthritis, MS, Parkinsons, Diabetes, Stroke, Alzheimers, Spinal Cord injuries, Cancer or Chronic Pain to name a few. A stem cell transplant, instead of a joint replacement, is fast becoming the preferred first option for orthopedic surgeons.

The Foundation intends to educate parents/carers of children suffering from a debilitating or degenerative condition like Cerebral Palsy, Muscular Dystrophy, Autism, Spinal injuries, Cystic fibrosis, ADHD etc. Stem cell treatments have progressed in leaps and bounds for these conditions. There are now state of the art clinics that specialize in treating the afore-mentioned conditions. Children can usually benefit substantially from an early intervention by stem cell therapies and other protocols because they are still growing. As an example: spending time in a mild hyperbaric chamber (HBO) can also be beneficial. Just fill out the Application Form for an experimental transplant and we will be only too happy to advise.

The ASCF has become a global Information Centre for stem cell therapy. The centre will only support clinics that have demonstrated they abide by the highest medical standards and have a proven track record of administering these types of therapies, in Australia and overseas. We can now advise locally which gives peace of mind to our members who are contemplating a procedure of this nature.

Creating awareness of the availability of stem cell therapy and that it has become viable for consideration.

To raise money from benefactors, including private and commercial sponsorships.

To provide medical and research reports on degenerative disease to doctors and health professionals.

To run awareness programs on Lifestyle Medicine promoting healthy foods that may prevent the onset of degenerative diseases. This includes stem cell stimulating natural products that are backed by science.

To provide information to schools on healthy diet and lifestyle plans. To provide scholarships and fellowships for the study of degenerative diseases and their treatment.

To support Adult Stem Cell research by leading Universities and Not For Profit organizations.

To open representative offices in other countries. Such offices are already established in Thailand, NZ, South Africa, India, UK and France

It is a free service giving doctors in full security and full control the ability to record and share patient stem cell data with other doctors. The following is an overview of the Registrys main features:

Australasian Stem Cell Registry Overview - Read more >>>

The ASCF has also introduced a new funding model for stem cell transplants - this new financing model is funded by the patients and their supporters.

The Foundation receives no government funding so we exist on the generosity of our members, the public and corporations. We hope if we can help improve your health outcomes that you may see your way clear at some future time to consider assisting with either your time or money to this worthwhile cause.

We would also like to point out that there are medical conditions today that are still beyond the scope of this new and exciting branch of medical science, which unfortunately means not everybody can be treated with stem cells at this stage. If you are in this category, it is even more important you follow the ASCF Prevention Plan (see below) and keep your health in the best possible state while science catches up. Science is moving very fast in the area of Regenerative Medicine.

See the article here:
Stem cell - ADULT STEM CELL THERAPY IS AVAILABLE NOW!

Posted in Stem Cell Treatments | Comments Off

Stem Cell Research – Journal – Elsevier

Posted: August 17, 2015 at 1:40 am

Stem Cell Research is dedicated to publishing high-quality manuscripts focusing on the biology and applications of stem cell research. Submissions to Stem Cell Research, may cover all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem cells, developmental studies, stem cell genomes, and translational research. Stem Cell Research publishes 6 issues a year.

The journal publishes

Original articles Short reports Review articles Communications Methods and reagents articles Lab Resource: Stem Cell Line

Stem Cell Research collaborates with journals published by Cell Press. Our editorial board is happy to consider submissions reviewed at Cell Stem Cell or other Cell Press journals which are considered to be scientifically sound, but not impactful enough for the readership of Cell Press journals. Authors should include their Cell Press reviews (which will be confirmed by Cell Press) for fast-track consideration. In SCR's fast track system, the SCR office will inform you within 3-5 days if the manuscript warrants further consideration for publication. The editors reserve the right to (a) reject the manuscript, (b) accept the manuscript with no further review, (c) send the manuscript out for further review, (d) require revisions based on the Cell Press or further reviews.

Hide full aims and scope

Link:
Stem Cell Research - Journal - Elsevier

Posted in Stem Cell Research | Comments Off

Page 1,769«..10 20..1,7681,7691,770 1,771..1,780 1,790..»

Stem Cell Therapy & Stem Cell Treatment – Cell Therapy …

Humanity Plus

index | WVU Statler College

STEM All-Female High School Camp – West Virginia University

Seattle Genetics: Advancing Antibody-Drug Conjugates for …

Stem Cell Therapy | Cellular Prolotherapy | Caring Medical

Stem Cell Safety

Therapeutic Cloning – Explore Stem Cells

Stem cell – ADULT STEM CELL THERAPY IS AVAILABLE NOW!

Stem Cell Research – Journal – Elsevier

Categories

Archives

Recommended Sites

Contact Us

Recent Posts